T cell‐mediated cytotoxicity against orthotopic TMZ‐resistant GBM was enhanced by increasing the proportion of CD4+CD25+FoxP3+ cells (Treg cells) and decreasing the proportion of Treg cells. The gene discussed is CD4; the disease is glioblastoma.